Published in Cancer Weekly, April 6th, 2004
The trial is based upon the clinical results reported at the AACR-NCI-EORTC meeting in November 2003 in which Telcyta demonstrated the ability to contribute to platinum-based chemotherapy without unanticipated...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.